GemcitabineAtypical haemolytic uraemic syndrome treated with eculizumab: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1580卷 / 1期

关键词：

D O I：

10.1007/s40278-015-11533-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：187 / 187

相关论文

共 50 条

[21] CarfilzomibAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 107 - 107
[22] CiprofloxacinFirst report of haemolytic uraemic syndrome: case report
Reactions Weekly, 2002, 911 (1) : 7 - 7
[23] ClopidogrelFirst report of haemolytic uraemic syndrome: case report
Reactions Weekly, 2000, 806 (1) : 7 - 7
[24] MercaptopurineAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2022, 1914 (1) : 284 - 284
[25] TacrolimusRecurrence of haemolytic uraemic syndrome: case report
Reactions Weekly, 2009, 1272 (1) : 30 - 30
[26] TozinameranAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2023, 1940 (1) : 393 - 393
[27] TozinameranAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2022, 1933 (1) : 405 - 405
[28] DocetaxelAtypical haemolytic uraemic syndrome : case report
Reactions Weekly, 2018, 1731 (1) : 97 - 97
[29] Eculizumab for atypical haemolytic uraemic syndrome: what next?
Fakhouri, Fadi
Fremeaux-Bacchi, Veronique
NATURE REVIEWS NEPHROLOGY, 2013, 9 (09) : 495 - 496
[30] Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
Patrick R. Walsh
Sally Johnson
Pediatric Nephrology, 2019, 34 : 1485 - 1492

← 1 2 3 4 5 →